Based on high tumor prevalence and a tumor-specific distribution (frequency ratio tumor-to-nontumor >5), CD8-positive clonotypes were predicted as candidate tumor-specific T cells (Figures 1B–D left graphs). This evidence concerns the gene CD8A and neoplasm.